スポンサーリンク
Department of Laboratory Medicine, Kawasaki Medical School | 論文
- Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality
- A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
- Effects of the Tyrosine Kinase Inhibitor Imatinib Mesylate on a Bcr-Abl-Positive Cell Line : Suppression of Autonomous Cell Growth but No Effect on Decreased Adhesive Property and Morphological Changes
- Diagnostic and biological significance of sideroblastic erythropoiesis in the myelodysplastic syndromes
- Hematological Diseases and Apoptosis
- Distribution of endogenous endonuclease activities capable of producing internucleosomal DNA cleavage in hematopoietic cells
- Reversible Acceleration of Disease Progression Following Cyclosporin A Treatment in a Patient With Myelodysplastic Syndrome
- The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma
- 5q-syndrome in Japan